Physician profile
John A White
NPI 1053422709
$8,189.93
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $163 · 2021: $419 · 2022: $317 · 2023: $205 · 2024: $6,492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,400 · Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,400.00 |
| Food and Beverage | $296.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $6,400.00 | 2024 | |
| Abbvie INC. | $433.23 | 2019-2023 | Lo Loestrin Fe |
| Pfizer INC. | $171.11 | 2019-2023 | |
| Duchesnay USA Incorporated | $151.77 | 2019 | |
| Exeltis, USA INC. | $126.08 | 2019-2023 | Slynd |
| Millicent US INC | $116.83 | 2019-2024 | Intrarosa, Femring |
| Therapeuticsmd, INC. | $73.50 | 2019-2022 | |
| Medtronic, INC. | $66.31 | 2021 | |
| Avion Pharmaceuticals | $56.50 | 2022-2023 | NP Thyroid 60, Divigel |
| Amgen INC. | $52.73 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $50.67 | 2021-2023 | |
| Myovant Sciences INC. | $48.78 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $48.72 | 2022 | |
| Smith+Nephew, INC. | $38.23 | 2024 | Pico 14, Stravix Pl |
| Ethicon US, LLC | $37.65 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $36.79 | 2021 | |
| Allergan, INC. | $28.42 | 2020 | |
| Medicem INC. | $26.10 | 2020 | |
| Hologic Sales and Service, LLC | $24.41 | 2019-2022 | |
| Lsi Solutions INC | $22.42 | 2021 | |
| Agile Therapeutics, INC. | $21.74 | 2021 | |
| Roche Diagnostics Corporation | $21.08 | 2019 | |
| Vertical Pharmaceuticals, LLC | $20.98 | 2019 | |
| Mallinckrodt Enterprises LLC | $18.70 | 2019 | |
| Olympus America INC. | $17.91 | 2023 | Olympus, 4k Camera Head |
| Sage Therapeutics, LLC | $17.75 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.09 | 2020 | |
| Shield Therapeutics INC | $15.93 | 2024 | |
| Bolder Surgical LLC | $14.96 | 2019 | |
| Davol INC. | $13.54 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.